BlackRock Inc. - ALTAMIRA THERAPEUTICS LTD ownership

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L100. A total of 16 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q1 2022$67,000
+9.8%
61,603
+84.2%
0.00%
Q4 2021$61,000
-6.2%
33,452
+2.6%
0.00%
Q3 2021$65,00032,5920.00%
Other shareholders
ALTAMIRA THERAPEUTICS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 320,010$351,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 30,753$34,0000.00%
Cutler Group LLC / CA 2,100$2,0000.00%
BARCLAYS PLC 1$00.00%
Gradient Investments LLC 1,000$1,0000.00%
Stonebridge Capital Advisors LLC 100$00.00%
UBS Group AG 3,486$4,0000.00%
OSAIC HOLDINGS, INC. 10$00.00%
WELLS FARGO & COMPANY/MN 500$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders